Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

A-Tocopherol protects against monosodium glutamate-induced hepatotoxicity via modulation of liver enzymes and collagen deposition in adult Wistar rats

View through CrossRef
Monosodium glutamate (MSG) is a flavor enhancing agent known for its potential adverse effects, particularly its toxicity to the liver through the induction of oxidative stress. The current study evaluated the protective potential of α-tocopherol on MSG-induced hepatotoxicity in adult Wistar rats. In this experiment, adult Wistar rats, 20 in number, each weighing between 160g and 170g, were systematically allocated into four groups made up of five rats per group: Group A (control group), Group B (administered 200 mg/kg body weight [BW] of MSG), Group C (received 100 IU/kg BW of vitamin E one hour prior to the MSG treatment), and Group D (given 100 IU/kg BW of vitamin E only). After administration, the rats were sacrificed, and liver function, oxidative stress markers, and histology were assessed. Results showed that MSG significantly increased ALT, AST, albumin, and total bilirubin levels, indicating altered liver enzyme activity. MSG also induced oxidative stress, evidenced by significantly decline [p<0.05] levels of antioxidant enzymes (superoxide dismutase, catalase and glutathione peroxidase) along with a significant elevation in malondialdehyde as well as zonal necrosis and mild Kupffer cell activation, with increased collagen deposit in the liver. However, treatment with α-tocopherol significantly improved liver enzyme biomarkers, increased antioxidant enzyme activity and reduced lipid peroxidation as well as marked improvements in liver histology as evidenced by relatively normal liver histoarchitecture and reduced deposits of collagen fibers. Evidences from this study suggest that α-tocopherol confers protective effects on MSG-induced hepatotoxicity by modulating oxidative stress, liver enzymes and collagen deposition, elaborating its potency as a therapeutic agent against hepatotoxicity.
Title: A-Tocopherol protects against monosodium glutamate-induced hepatotoxicity via modulation of liver enzymes and collagen deposition in adult Wistar rats
Description:
Monosodium glutamate (MSG) is a flavor enhancing agent known for its potential adverse effects, particularly its toxicity to the liver through the induction of oxidative stress.
The current study evaluated the protective potential of α-tocopherol on MSG-induced hepatotoxicity in adult Wistar rats.
In this experiment, adult Wistar rats, 20 in number, each weighing between 160g and 170g, were systematically allocated into four groups made up of five rats per group: Group A (control group), Group B (administered 200 mg/kg body weight [BW] of MSG), Group C (received 100 IU/kg BW of vitamin E one hour prior to the MSG treatment), and Group D (given 100 IU/kg BW of vitamin E only).
After administration, the rats were sacrificed, and liver function, oxidative stress markers, and histology were assessed.
Results showed that MSG significantly increased ALT, AST, albumin, and total bilirubin levels, indicating altered liver enzyme activity.
MSG also induced oxidative stress, evidenced by significantly decline [p<0.
05] levels of antioxidant enzymes (superoxide dismutase, catalase and glutathione peroxidase) along with a significant elevation in malondialdehyde as well as zonal necrosis and mild Kupffer cell activation, with increased collagen deposit in the liver.
However, treatment with α-tocopherol significantly improved liver enzyme biomarkers, increased antioxidant enzyme activity and reduced lipid peroxidation as well as marked improvements in liver histology as evidenced by relatively normal liver histoarchitecture and reduced deposits of collagen fibers.
Evidences from this study suggest that α-tocopherol confers protective effects on MSG-induced hepatotoxicity by modulating oxidative stress, liver enzymes and collagen deposition, elaborating its potency as a therapeutic agent against hepatotoxicity.

Related Results

Chronic toxicity of low dose monosodium glutamate in albino Wistar rats
Chronic toxicity of low dose monosodium glutamate in albino Wistar rats
Abstract Objective The objective of this study was to observe the effects of chronic dosing with monosodium glutamate on mortality, fertility, major organ functions and histology ...
Functional Impact of nTS Glutamate Stress on Respiration in an Alzheimer’s Disease Model
Functional Impact of nTS Glutamate Stress on Respiration in an Alzheimer’s Disease Model
Alzheimer’s disease (AD) is closely associated with obstructive sleep apnea (OSA). Such hypoxic insults trigger glutamate release of chemoafferents into the nucleus tractus solitar...
In Vivo and In Vitro Studies Assessing the Safety of Monosodium Glutamate
In Vivo and In Vitro Studies Assessing the Safety of Monosodium Glutamate
The controversial results of research on monosodium glutamate demand a new data corpus for the overall safety evaluation. Both animal and cellular model systems have been used to a...
Abstract 2094: Regulation of site-specific liver metastasis by collagen IV-conveyed signals
Abstract 2094: Regulation of site-specific liver metastasis by collagen IV-conveyed signals
Abstract The liver is a primary site of metastasis for some of the most common human malignancies. At present, surgical resection is the most effective curative opti...
Effects of Turmeric Rhizome Powder Supplemented Diet on Indomethacin-induced Toxicity in Wistar Rats
Effects of Turmeric Rhizome Powder Supplemented Diet on Indomethacin-induced Toxicity in Wistar Rats
Turmeric (Curcuma longa) L rhizome powder (TRP) was commonly reported to have antiulcerogenic and non-toxicity effects. However, the scientific evidence showing the effectiveness o...
Case Reports on Severe Antituberculosis-Drug Induced Hepatotoxicity in Tuberculosis Patients: The Post-Incidence Therapy
Case Reports on Severe Antituberculosis-Drug Induced Hepatotoxicity in Tuberculosis Patients: The Post-Incidence Therapy
Introduction:  The first-line regimen for tuberculosis (TB) treatment comprises Isoniazid, Rifampicin, Pyrazinamide, and Ethambutol. However, these drugs are known to potentially c...

Back to Top